- Adherence
- Children
- Clinical reviews
- Drug supply
- Guidelines
- Hepatitis and HIV coinfection
- HIV Testing
- Infant feeding
- Laboratory monitoring
- Malaria & HIV
- Neurological problems, including HIV dementia
- Nutrition
- Palliative care
- Prevention
- Prevention of mother-to child transmission
- Scaling up treatment and models of service delivery
- First-line antiretroviral therapy: not as simple as we'd like it to be - 19/06/08
- How to deliver good adherence support: lessons from round the world - 10/9/2007
- A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
- Towards a comprehensive package of preventive and palliative care - 17/8/2007
- HIV treatment and displaced populations - 27/6/2007
- Brazil’s HIV/AIDS programme is a model for the rest of the world, but the cost of second-line therapies and the spread of HIV-1C could spell danger for the future - 27/10/2005
- Former manager of Botswana’s antiretroviral treatment programme describes barriers to rapid scale-up and suggest possible solutions at 2nd South African AIDS Conference - 27/10/2005
- Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part One - 27/10/2005
- Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part Two - 27/10/2005
- Getting antiretrovirals to where they are needed: drug procurement and quality - 27/10/2005
- Laboratory requirements for scaling up HIV treatment - 27/10/2005
- CDC pioneers family-based "preventive care" in Uganda as framework for rollout - 27/10/2005
- Integrating prevention research into the provision of HIV care - 23/5/2006
- Delivering 3 X 5: what are the next steps? - 27/10/2005
- Learning from Botswana - 27/10/2005
- MTCT-plus: Family-focused care and treatment - 27/10/2005
- Professional roles and ARV provision - 27/10/2005
- Amsterdam workshop on scaling up treatment (meeting report) - 27/10/2005
- Side-effects
- South Africa
- Starting treatment
- Stigma
- Task shifting
- Treatment failure
- Tuberculosis
- Viral load testing
Scaling up treatment and models of service delivery
First-line antiretroviral therapy: not as simple as we'd like it to be - 19/06/08
How to deliver good adherence support: lessons from round the world - 10/9/2007
A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
Towards a comprehensive package of preventive and palliative care - 17/8/2007
HIV treatment and displaced populations - 27/6/2007
Brazil’s HIV/AIDS programme is a model for the rest of the world, but the cost of second-line therapies and the spread of HIV-1C could spell danger for the future - 27/10/2005
Former manager of Botswana’s antiretroviral treatment programme describes barriers to rapid scale-up and suggest possible solutions at 2nd South African AIDS Conference - 27/10/2005
Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part One - 27/10/2005
Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part Two - 27/10/2005
Getting antiretrovirals to where they are needed: drug procurement and quality - 27/10/2005
Laboratory requirements for scaling up HIV treatment - 27/10/2005
CDC pioneers family-based "preventive care" in Uganda as framework for rollout - 27/10/2005
Integrating prevention research into the provision of HIV care - 23/5/2006
Delivering 3 X 5: what are the next steps? - 27/10/2005
Learning from Botswana - 27/10/2005
MTCT-plus: Family-focused care and treatment - 27/10/2005
Professional roles and ARV provision - 27/10/2005
Amsterdam workshop on scaling up treatment (meeting report) - 27/10/2005
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- High rate of death amongst patients with HIV diagnosed late
- Study explores verbal and non-verbal communication in unprotected sex between men
- IL-2 provides quick ‘AIDS rescue’, but effect does not always last
- Once-a-day etravirine should work as first-line treatment
- Second-line combinations fail twice as often as first-line ones in the first year
- If you can't switch, better to stay on failing treatment than stop it, studies show
- Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’
- One in five Kenyan patients suffers major interactions with HIV drugs
- HIV treatment safe and effective in South African patients with hepatitis B co-infection, but co-infection frequent
- Treatment breaks set for a come-back?